These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Deazaflavin Inhibitors of Tyrosyl-DNA Phosphodiesterase 2 (TDP2) Specific for the Human Enzyme and Active against Cellular TDP2. Marchand C; Abdelmalak M; Kankanala J; Huang SY; Kiselev E; Fesen K; Kurahashi K; Sasanuma H; Takeda S; Aihara H; Wang Z; Pommier Y ACS Chem Biol; 2016 Jul; 11(7):1925-33. PubMed ID: 27128689 [TBL] [Abstract][Full Text] [Related]
6. Repair of trapped topoisomerase II covalent cleavage complexes: Novel proteasome-independent mechanisms. Tsuda M; Kitamasu K; Hosokawa S; Nakano T; Ide H Nucleosides Nucleotides Nucleic Acids; 2020; 39(1-3):170-184. PubMed ID: 31608820 [TBL] [Abstract][Full Text] [Related]
7. Genome-Wide CRISPR Screens Reveal ZATT as a Synthetic Lethal Target of TOP2-Poison Etoposide That Can Act in a TDP2-Independent Pathway. Park JM; Zhang H; Nie L; Wang C; Huang M; Feng X; Tang M; Chen Z; Xiong Y; Lee N; Li S; Yin L; Hart T; Chen J Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047518 [TBL] [Abstract][Full Text] [Related]
8. Effect of TDP2 on the Level of TOP2-DNA Complexes and SUMOylated TOP2-DNA Complexes. Lee KC; Swan RL; Sondka Z; Padget K; Cowell IG; Austin CA Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30011940 [TBL] [Abstract][Full Text] [Related]
9. Cancer sensitizing effect of deazaflavin analogs is associated with increased intracellular drug accumulation. Belhadj Z; Offei S; Jacobson BA; Cambron D; Kratzke RA; Wang Z; Xie J Eur J Pharm Sci; 2024 Feb; 193():106686. PubMed ID: 38159687 [TBL] [Abstract][Full Text] [Related]
10. Proteolytic degradation of topoisomerase II (Top2) enables the processing of Top2·DNA and Top2·RNA covalent complexes by tyrosyl-DNA-phosphodiesterase 2 (TDP2). Gao R; Schellenberg MJ; Huang SY; Abdelmalak M; Marchand C; Nitiss KC; Nitiss JL; Williams RS; Pommier Y J Biol Chem; 2014 Jun; 289(26):17960-9. PubMed ID: 24808172 [TBL] [Abstract][Full Text] [Related]
11. TDP2/TTRAP is the major 5'-tyrosyl DNA phosphodiesterase activity in vertebrate cells and is critical for cellular resistance to topoisomerase II-induced DNA damage. Zeng Z; Cortés-Ledesma F; El Khamisy SF; Caldecott KW J Biol Chem; 2011 Jan; 286(1):403-9. PubMed ID: 21030584 [TBL] [Abstract][Full Text] [Related]
12. TDP2-dependent non-homologous end-joining protects against topoisomerase II-induced DNA breaks and genome instability in cells and in vivo. Gómez-Herreros F; Romero-Granados R; Zeng Z; Alvarez-Quilón A; Quintero C; Ju L; Umans L; Vermeire L; Huylebroeck D; Caldecott KW; Cortés-Ledesma F PLoS Genet; 2013; 9(3):e1003226. PubMed ID: 23505375 [TBL] [Abstract][Full Text] [Related]
13. TDP2 promotes repair of topoisomerase I-mediated DNA damage in the absence of TDP1. Zeng Z; Sharma A; Ju L; Murai J; Umans L; Vermeire L; Pommier Y; Takeda S; Huylebroeck D; Caldecott KW; El-Khamisy SF Nucleic Acids Res; 2012 Sep; 40(17):8371-80. PubMed ID: 22740648 [TBL] [Abstract][Full Text] [Related]
14. Discovery, enantioselective synthesis of myrtucommulone E analogues as tyrosyl-DNA phosphodiesterase 2 inhibitors and their biological activities. Zhang Y; Yang H; Wang FT; Peng X; Liu HY; Li QJ; An LK Eur J Med Chem; 2022 Aug; 238():114445. PubMed ID: 35580424 [TBL] [Abstract][Full Text] [Related]
15. Inactivating TDP2 missense mutation in siblings with congenital abnormalities reminiscent of fanconi anemia. Zagnoli-Vieira G; Brazina J; Van Den Bogaert K; Huybrechts W; Molenaers G; Caldecott KW; Van Esch H Hum Genet; 2023 Sep; 142(9):1417-1427. PubMed ID: 37558815 [TBL] [Abstract][Full Text] [Related]
16. Mode of action of DNA-competitive small molecule inhibitors of tyrosyl DNA phosphodiesterase 2. Hornyak P; Askwith T; Walker S; Komulainen E; Paradowski M; Pennicott LE; Bartlett EJ; Brissett NC; Raoof A; Watson M; Jordan AM; Ogilvie DJ; Ward SE; Atack JR; Pearl LH; Caldecott KW; Oliver AW Biochem J; 2016 Jul; 473(13):1869-79. PubMed ID: 27099339 [TBL] [Abstract][Full Text] [Related]
17. Reversal of DNA damage induced Topoisomerase 2 DNA-protein crosslinks by Tdp2. Schellenberg MJ; Perera L; Strom CN; Waters CA; Monian B; Appel CD; Vilas CK; Williams JG; Ramsden DA; Williams RS Nucleic Acids Res; 2016 May; 44(8):3829-44. PubMed ID: 27060144 [TBL] [Abstract][Full Text] [Related]
18. Novel TDP2-ubiquitin interactions and their importance for the repair of topoisomerase II-mediated DNA damage. Rao T; Gao R; Takada S; Al Abo M; Chen X; Walters KJ; Pommier Y; Aihara H Nucleic Acids Res; 2016 Dec; 44(21):10201-10215. PubMed ID: 27543075 [TBL] [Abstract][Full Text] [Related]
19. Toxoflavins and deazaflavins as the first reported selective small molecule inhibitors of tyrosyl-DNA phosphodiesterase II. Raoof A; Depledge P; Hamilton NM; Hamilton NS; Hitchin JR; Hopkins GV; Jordan AM; Maguire LA; McGonagle AE; Mould DP; Rushbrooke M; Small HF; Smith KM; Thomson GJ; Turlais F; Waddell ID; Waszkowycz B; Watson AJ; Ogilvie DJ J Med Chem; 2013 Aug; 56(16):6352-70. PubMed ID: 23859074 [TBL] [Abstract][Full Text] [Related]
20. FEN1 participates in repair of the 5'-phosphotyrosyl terminus of DNA single-strand breaks. Kametani Y; Takahata C; Narita T; Tanaka K; Iwai S; Kuraoka I Carcinogenesis; 2016 Jan; 37(1):56-62. PubMed ID: 26581212 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]